Neoadjuvant Chemoradiation in Patient with Localy Advanced Rectal Cancer

1. Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, Dorval E, de Calan L, Huten N, le Folch O, Calais G. Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. // Int J Radiat OncolBiol Phys,1997;37(3):619-62710.1016/S0360-3016(96)00577-9Search in Google Scholar

2. CalvoFA, Gomez-Espi M, Diaz-Gonzalez JA, Cantalapiedra R, Marcos P, Alvarado A, Garcia Alfonso P, Herranz R, Alvarez E, Calvo FA, Gomez- Espi M, Diaz-Gonzalez JA. Pathologic downstaging of T3-4Nx rectal cancer after chemoradiation: 5-fluorouracil vs. Tegafur.// Int J Radiat Oncol Biol Phys, 2001; 51 (5):1264-70Search in Google Scholar

3. Calvo FA, Serrano FJ, Diaz-Gonzalez JA, Gomez- Espi M, Lozano E, Garcia R, de la Mata D, Arranz JA, Garcia-Alfonso P, Perez-Manga G, Alvarez E. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation. // AnnOncol, 2006;17(7):1103-111010.1093/annonc/mdl08516670204Search in Google Scholar

4. Diaz-Gonzalez JA, Calvo FA, Cortes J, de La Mata D, Gomez-Espi M, Lozano MA, Lozano E, Serrano J, Herranz R. Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer. // Int J Radiat OncolBiol Phys, 2005;61(5):1378-138410.1016/j.ijrobp.2004.08.01815817340Search in Google Scholar

5. Latvian Cancer RegistrySearch in Google Scholar

6. Liersch T, Langer C, Ghadimi BM. Lymph nodestatus and TS gene expression are prognostic markers instage II/III rectal cancer after neoadjuvant fluorouracil-basedchemoradiotherapy. // J Clin Oncol, 2006;24(25):4062-406810.1200/JCO.2005.04.273916943523Search in Google Scholar

7. Ortholan C, Francois E, Thomas O. Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials. // Dis Colon Rectum, 2006; 49(3):302-31010.1007/s10350-005-0263-x16456638Search in Google Scholar

8. Quah HM, Chou JF, Gonen M. Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. // Cancer, 2008;113(1):57-6410.1002/cncr.2351618442099Search in Google Scholar

9. R¨odel C, Martus P, Papadoupolos T. Prognosticsignificance of tumor regression after preoperative chemoradiotherapyfor rectal cancer. // J ClinOncol, 2005;23(34):8688-869610.1200/JCO.2005.02.132916246976Search in Google Scholar

10. Sauer R, Becker H, Hohenberger W. Preoperative versus postoperative chemoradiotherapy for rectal cancer. // N Engl J Med, 2004;351(17):1731-181010.1056/NEJMoa04069415496622Search in Google Scholar

11. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. // N Engl J Med, 1997;345:980-987 Search in Google Scholar